Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856407) titled 'Educational Needs of Patients With Severe Asthma on Targeted Immunotherapies' o... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856459) titled 'ABVN Phase 2 - EDS Wearable Device' on Sept. 28. Study Type: Interventional ... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856511) titled 'A Study to Evaluate the Efficacy and Safety of Proximod in Patients With Rheuma... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856602) titled 'Safety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frail... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856654) titled 'Suzetrigine Following Urogynecologic Surgery: Investigation of Postoperative Pa... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856147) titled 'Comparison of Transverse Friction Massage and Instrument- Assisted Soft-Tissue ... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856251) titled 'Lidocaine Infusions for Pain in Patients With Malignant Bowel Obstruction' on S... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856303) titled 'SHR-A1811 Versus Trastuzumab Plus Pertuzumab in ctDNA-Positive HER2-Positive Ea... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856342) titled 'Megagon Magnet Anastomosis Plus OTOLoc for Creating Colo-colonic and Colorectal... Read More
Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856446) titled 'ABVN Phase 2 - PENFS' on Sept. 28. Study Type: Interventional Study Design: ... Read More